Les freins à l'utilisation des bêtabloquants chez les patients hypertendus à risque métabolique : aspects cliniquesZANNAD, Faïez.Archives des maladies du coeur et des vaisseaux. Pratique. 2007, Num 157, pp 9-11, issn 1261-694X, 3 p., SUPConference Paper

Effets des inhibiteurs calciques sur la progression de l'athérosclérose et de l'épaisseur intima média = Effects of calcium antagonists on the progression of atherosclerosis and intima media thicknessZANNAD, Faiez.Drugs (Basel). 2000, Vol 59, pp 39-46, issn 0012-6667, NS2Article

Modern management of acute heart failure syndromesGHEORGHIADE, Mihai; ZANNAD, Faiez.European heart journal supplements. 2005, Vol 7, Num B, pp B3-B7, issn 1520-765XConference Paper

Acute heart failure syndromes: the 'Cinderella' of heart failure researchZANNAD, Faiez.European heart journal supplements. 2005, Vol 7, Num B, pp B8-B12, issn 1520-765XConference Paper

Reducing Cardiovascular Risk: Evidence From the ONTARGET ProgrammeFERRARI, Roberto; ZANNAD, Faiez.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, 55 p.Conference Proceedings

Benefits of first-line combination of perindopril and indapamide in clinical practice for patients with hypertension and diabetesZANNAD, Faiez.American journal of hypertension. 2007, Vol 20, Num 7, issn 0895-7061, 9S-14S, SUPConference Paper

The potential advantages of a modern antihypertensive therapy in the elderlyZANNAD, Faiez.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 1, pp S19-S23Conference Paper

Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists : an overview of randomized controlled studiesZANNAD, Faiez; FAY, Renaud.Fundamental & clinical pharmacology. 2007, Vol 21, Num 2, pp 181-190, issn 0767-3981, 10 p.Article

Loop diuretics and ultrafiltration in heart failureROSSIGNOL, Patrick; ZANNAD, Faiez.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 12, pp 1641-1648, issn 1465-6566, 8 p.Article

Les recommandations et le guide « Affections de longue durée » dans l'hypertension artérielle sévère : Hypertensions artérielles particulières = Official recommendations and guidelines for the management and reimbursement of severe hypertension as a chronic diseaseBOIVIN, Jean-Marc; ZANNAD, Faiez.La Presse médicale (1983). 2009, Vol 38, Num 4, pp 652-660, issn 0755-4982, 9 p.Article

Aldostérone et complications du post-infarctusZANNAD, Faiez; HITTINGER, Luc.Archives des maladies du coeur et des vaisseaux. Pratique. 2006, Num nov, pp 6-8, issn 1261-694X, 3 p., NSConference Paper

Acute heart failure syndromes: a reassessment of current therapiesGHEORGHIADE, Mihai; ZANNAD, Faiez.European heart journal supplements. 2005, Vol 7, Num B, issn 1520-765X, 32 p.Conference Proceedings

Targeting blood pressure in the management of total cardiovascular riskMANCIA, Giuseppe; CORRAO, Giovanni.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F27-F32Conference Paper

The rationale for choosing telmisartan and ramipril in the ONTARGET programmeUNGER, Thomas.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F3-F8Conference Paper

Sympathetic-leptin relationship in obesity : effect of weight lossQUILLOT, Didier; BÖHME, Philip; ZANNAD, Faiez et al.Metabolism, clinical and experimental. 2008, Vol 57, Num 4, pp 555-562, issn 0026-0495, 8 p.Article

Reassessing treatment of acute heart failure syndromes: the ADHERE RegistryGHEORGHIADE, Mihai; FILIPPATOS, Gerasimos.European heart journal supplements. 2005, Vol 7, Num B, pp B13-B19, issn 1520-765XConference Paper

Benefits, challenges, and registerability of the polypillSLEIGHT, Peter; POULEUR, Hubert; ZANNAD, Faiez et al.European heart journal. 2006, Vol 27, Num 14, pp 1651-1656, issn 0195-668X, 6 p.Article

Clinical evidence from ONTARGET: proven cardio- and vascular protectionTEO, Koon K.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F9-F15Conference Paper

Further evidence from ONTARGET: additional vascular protectionSLEIGHT, Peter.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F16-F18Conference Paper

Proposition d'un outil de transmission au patient des résultats globaux de la recherche biomédicale = Proposal of a tool for providing patients with the main results of clinical research studiesDUCKI, Camille; ROSE, Audrey; RADAUCEANU, Anca et al.Thérapie (Paris). 2005, Vol 60, Num 6, pp 545-551, issn 0040-5957, 7 p.Article

Prise en charge du risque cardiovasculaire : nouvelles perspectives avec l'amlodipine : revue d'actualité = Management of cardiovascular risk: new perspectives with amlodipine: a seminar-in-printZANNAD, Faiez; GIRERD, Xavier; WEBER, Simon et al.Drugs (Basel). 2000, Vol 59, issn 0012-6667, 56 p., NS2Serial Issue

Information du public sur les essais cliniques et la recherche = Public information about clinical trials and researchPLETAN, Yannick; ZANNAD, Faïez; JAILLON, Patrice et al.Thérapie (Paris). 2003, Vol 58, Num 3, pp 185-208, issn 0040-5957, 24 p.Conference Paper

Prevention of stroke: new evidenceDAHLÖF, Björn.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F33-F38Conference Paper

Vascular protection: telmisartan in the ONTARGET Trial ProgrammeDAGENAIS, Gilles R.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F47-F53Conference Paper

Impaired response of cardiac autonomic nervous system to glucose load in severe obesityQUILLIOT, Didier; ZANNAD, Faiez; ZIEGLER, Olivier et al.Metabolism, clinical and experimental. 2005, Vol 54, Num 7, pp 966-974, issn 0026-0495, 9 p.Article